The Defense Department’s Strategic and Critical Materials Review

MAY 28, 2021 | Announcement

As part of the national response to COVID-19, the Department of Defense (DoD), in coordination with the Department of Health and Human Services (HHS), signed an agreement with Retractable Technologies, Inc. to expand the production of low dead-space (LDS) safety syringes and needles. Government funding allocated was $27.3 million. LDS syringes maximize dose efficiency and allow for additional vaccinations to be obtained from vials. Additional information on the agreement may be found here.

To view more Industrial Base Policy Announcements click here.